Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Blood Loss in Second Trimester Abortion
NCT06078501Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in second trimester abortion comparing Misoprostol with Placebo (2 arms). Primary endpoint: Number of Participants With Hemorrhage Greater Than 500 mL as a Measure of Quantified Blood Loss. Started Feb 2024; status: terminated.
02
Drugs
misoprostol
03
Conditions
second trimester abortion
Beyond the preview
Go deeper on NCT06078501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06078501.